AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
AJPB® August 2022
Advertisement
Advertisement
Trending on Pharmacy Times
1
Outcomes of Older Patients on Enfortumab Vedotin for Urothelial Carcinoma
2
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
3
ADA 2026: Lipid Management and Cardiovascular Prevention Updates for People With Diabetes
4
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence
5